Francesco Marampon

Pubblicazioni

Titolo Pubblicato in Anno
Definitive weekly hypofractionated radiotherapy in surgery-ineligible older adults with cutaneous squamous cell carcinoma of the head and neck region JOURNAL OF GERIATRIC ONCOLOGY 2024
Statin-Sensitive Akt1/Src/Caveolin-1 Signaling Enhances Oxidative Stress Resistance in Rhabdomyosarcoma CANCERS 2024
DNA Damage Response Gene Signature as Potential Treatment Markers for Oral Squamous Cell Carcinoma INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 2023
Spermine oxidase induces DNA damage and sensitizes fusion negative rhabdomyosarcoma cells to irradiation FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY 2023
Clinical efficacy of adjuvant radiotherapy for WHO grade II intracranial meningioma WORLD NEUROSURGERY 2023
Abscopal Effect on Bone Metastases from Solid Tumors: A Systematic Review and Retrospective Analysis of Challenge within a Challenge BIOMEDICINES 2023
Radio-guided lung surgery: a feasible approach for a cancer precision medicine DIAGNOSTICS 2023
Extraosseous distribution of 99mTc-diphosphonates during bone scintigraphy: review of the literature with case series presentation INTERNATIONAL JOURNAL OF RADIATION BIOLOGY 2023
Anti-proliferative, pro-apototic and anti-migratory properties of HDAC inhibitor PXD-101 on osteosarcoma cell lines ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS 2023
DNA repair in tumor radioresistance: insights from fruit flies genetics CELLULAR ONCOLOGY 2023
MYOD-SKP2 axis boosts tumorigenesis in fusion negative rhabdomyosarcoma by preventing differentiation through p57Kip2 targeting NATURE COMMUNICATIONS 2023
ATX-101, a peptide targeting PCNA, has antitumor efficacy alone or in combination with radiotherapy in murine models of human glioblastoma CANCERS 2022
The botanical drug PBI-05204, a supercritical CO2 extract of nerium oleander, is synergistic with radiotherapy in models of human glioblastoma FRONTIERS IN PHARMACOLOGY 2022
MET inhibition sensitizes rhabdomyosarcoma cells to NOTCH signaling suppression FRONTIERS IN ONCOLOGY 2022
Anti‑oncogenic and pro‑myogenic action of the MKK6/p38/AKT axis induced by targeting MEK/ERK in embryonal rhabdomyosarcoma ONCOLOGY REPORTS 2022
Abstract 6307: The botanical drug PBI-05204, a supercritical CO2 extract of Nerium oleander, augments the antitumor efficacy of radiotherapy in treatment of human glioblastoma CANCER RESEARCH 2022
Radioresistance in rhabdomyosarcomas: much more than a question of dose FRONTIERS IN ONCOLOGY 2022
Translational implications for radiosensitizing strategies in rhabdomyosarcoma INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 2022
The botanical drug PBI-05204, a supercritical CO2 extract of Nerium oleander, sensitizes alveolar and embryonal rhabdomyosarcoma to radiotherapy in vitro and in vivo FRONTIERS IN PHARMACOLOGY 2022
Radioresistance Mechanisms in Prostate Cancer Cell Lines Surviving Ultra-Hypo-Fractionated EBRT: Implications and Possible Clinical Applications CANCERS 2022

Progetti di Ricerca

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma